Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0436-2021Class II

OsteoBridge Intramedullary Diaphysis Segment Fixation (IDSF) nails (femur)

Merete GmbH / initiated 2020-09-18 / Terminated / root cause: manufacturing process

Merete Medical GmbH began a recall of OsteoBridge Intramedullary Diaphysis Segment Fixation (IDSF) nails (femur) on . FDA classified it as Class II and gives the reason as "Product may be mislabeled". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0436-2021
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Merete GmbH
Product
OsteoBridge Intramedullary Diaphysis Segment Fixation (IDSF) nails (femur)
Product code
HSB Rod, Fixation, Intramedullary And Accessories
Reason for recall
Product may be mislabeled.
Root cause tag
manufacturing process
FDA root cause
Process design
Action
The recalling firm contacted their importer via email to notify them of the recall. The importer contacted impacted distributors by phone to notify them of the incident and ask that product be shipped back. Customers were provided with overnight shipping labels to ship the product back to the importer. The recalling firm will reconcile returned product quantities against shipping records to ensure all product is returned.
Quantity in commerce
354 units
Distribution
Product was distributed in US - CA, IL, MD, OH, and NJ
Product codes and lots
Lot Number Use By Date  MS1913083R 6/4/2025 MS1811571R 7/24/2025 MS1913083R1 7/24/2025 MS1913084R 6/4/2025 MS1811572R 7/17/2025 MS1811572R1 7/24/2025 MS1913085R 6/4/2025 MS1811573R 7/17/2025 MS1913086R 6/4/2025 MS1811660R 7/17/2025 MS1913087R 6/4/2025 MS1913087R 6/4/2025 MS1811661R 7/17/2025 MS1912446R 7/17/2025 MS1913087R1 7/17/2025 MS1913098R 6/4/2025 MS1811613R 7/17/2025 MS1913099R 6/4/2025 MS1811614R 7/17/2025 MS1913100R 6/4/2025 MS1913100R 6/4/2025 MS1811662R 7/17/2025 MS1913100R1 7/17/2025 MS1811663R 6/4/2025 MS1811663R1 7/17/2025 MS1913102R 6/4/2025 MS1913102R 6/4/2025 MS1913102R1 7/17/2025 MS1811664R 7/17/2025 MS1913114R 6/4/2025 MS1913114R 6/4/2025 MS1811618R 7/17/2025 MS1913114R1 7/17/2025 MS1913115R 6/4/2025 MS1913115R 6/4/2025 MS1811665R 7/21/2025 MS1913115R1 7/21/2025 MS1913116R 6/4/2025 MS1913116R 6/4/2025 MS1811666R 7/21/2025 MS1913117R 6/4/2025 MS1913117R 6/4/2025 MS1913117R1 7/21/2025 MS1811667R 7/21/2025 MS1913118R 6/4/2025 MS1913118R 6/4/2025 MS1811668R 7/21/2025 MS1912441R 7/21/2025 MS1811642R 6/4/2025 MS1913126R 6/4/2025 MS1811642R 6/4/2025 MS1913126R 6/4/2025 MS1913126R 6/4/2025 MS1811642R 6/4/2025 MS1811642R1 7/21/2025 MS1913127R 6/4/2025 MS1811882R 7/21/2025 MS1811643R 7/22/2025 MS1913128R 6/4/2025 MS1913128R 6/4/2025 MS1912443R 7/21/2025 MS1811644R 7/21/2025 MS1913129R 6/4/2025 MS1913129R 6/4/2025 MS1912444R 7/21/2025 MS1811645R 7/21/2025 MS1913130R 6/4/2025 MS1811619R 7/21/2025 MS1913131R 6/4/2025 MS1811646R 7/21/2025 MS1913132R 6/4/2025 MS1811620R 7/21/2025 MS1913133R 6/4/2025 MS1811647R 7/24/2025

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0436-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0435-2021Class IITerminatedVoluntary: Firm initiated
Z-0436-2021Class IITerminatedVoluntary: Firm initiated
Z-0437-2021Class IITerminatedVoluntary: Firm initiated
Z-0438-2021Class IITerminatedVoluntary: Firm initiated